As medications such as Mounjaro (tirzepatide) and Wegovy (semaglutide) have become increasingly popular for weight management, a new term has emerged online: GLP-1 microdosing.

Some people claim that taking smaller doses helps reduce side effects while still supporting weight loss. Others wonder whether they can stay on a lower dose once they've reached their goals.

So, what does the science actually say?

In this guide, we'll explain what GLP-1 microdosing is, its potential advantages and disadvantages, and why any decision about your dose should always be made with a qualified healthcare professional.

What is GLP-1 microdosing?

There is no official medical definition of GLP-1 microdosing.

Generally, the term refers to taking a lower dose than the standard maintenance dose of a GLP-1 medication, or increasing doses more slowly than the usual treatment schedule.

People may use the term when they:

• Stay on a lower dose for longer.
• Delay increasing to the next dose.
• Ask to reduce their dose after losing weight.
• Take a smaller dose than prescribed (which should never be done without medical advice).

It's important to remember that microdosing is not currently an approved dosing strategy for licensed GLP-1 medications used for weight management.

Why are people interested in microdosing?

Every person's weight management journey is different.

Some patients achieve good appetite control on lower doses, while others experience side effects when increasing their medication.

Common reasons people ask about microdosing include:

• Reducing nausea or digestive side effects.
• Feeling their appetite is already well controlled.
• Wanting to maintain their weight after reaching their target.
• Concerns about increasing to a higher dose.
• Hoping to improve long-term affordability.

These are understandable questions, but they should always be discussed with your prescribing clinician rather than managed independently.

Potential benefits of microdosing

Although research is still evolving, some patients may experience benefits from remaining on a lower dose when clinically appropriate.

Better tolerability

One of the most common reasons for staying on a lower dose is to help manage side effects such as:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Stomach discomfort

If side effects are affecting your daily life, your clinician may recommend remaining on your current dose for longer before considering an increase.

Appetite control may already be sufficient

Not everyone responds to GLP-1 medications in the same way.

Some people find that a lower dose provides enough appetite suppression to support their weight management goals.

In these situations, your clinician may decide that increasing the dose immediately isn't necessary.

A personalised treatment approach

Weight management isn't one-size-fits-all.

Your ideal dose depends on several factors, including:

• Your response to treatment.
• Your weight loss progress.
• Side effects.
• Overall health.
• Your long-term goals.

For some patients, slower dose progression may be appropriate.

Potential drawbacks of microdosing

While lower doses may suit some individuals, there are also important limitations to consider.

Limited clinical evidence

Most of the large clinical studies for GLP-1 medications were based on the licensed dosing schedules.

There is currently limited evidence supporting long-term microdosing as a routine strategy for improving weight loss outcomes.

This means clinicians should carefully assess each patient's circumstances before recommending any deviation from the standard dosing schedule.

Reduced effectiveness

For some patients, remaining on a lower dose may not provide enough appetite control over time.

If hunger returns or weight loss plateaus, a dose increase may be appropriate.

Self-adjusting doses can be risky

Changing your own dose without medical advice can:

• Reduce treatment effectiveness.
• Increase the risk of side effects.
• Make it more difficult for your clinician to assess your progress.
• Lead to medication errors.

Always follow the dosing plan agreed with your healthcare professional.

Is microdosing safe?

The answer depends on why the dose is lower and who is making that decision.

A lower dose may be appropriate if your clinician believes it provides the right balance between effectiveness and tolerability.

However, taking less medication than prescribed on your own is not recommended.

Your treatment should always be based on a professional clinical assessment, regular follow-up and ongoing review.

What happens if a lower dose stops working?

Weight management is rarely a straight line.

Your body's response to treatment may change over time.

If your appetite increases, your weight loss slows, or your goals change, your clinician may recommend:

• Remaining on your current dose for longer.
• Increasing to the next licensed dose.
• Reviewing your diet and physical activity.
• Considering an alternative treatment where appropriate.

Regular reviews help ensure your treatment continues to meet your needs.

How Cannaray Wellness approaches GLP-1 dosing

At Cannaray Wellness, we know that no two patients respond to GLP-1 treatment in exactly the same way.

That's why we don't believe in a one-size-fits-all approach.

Every patient is reviewed individually by an independent clinician, who considers:

• Your weight loss progress.
• Your appetite and hunger levels.
• Any side effects you're experiencing.
• Your medical history.
• Your treatment goals.

If you're doing well on your current dose, we'll assess whether it's appropriate to continue. If you're experiencing side effects or your treatment no longer feels effective, we'll review your options with you.

Rather than automatically increasing every patient to the highest dose, our focus is on finding the dose that's right for you, balancing effectiveness, tolerability and long-term success.

Throughout your journey, we carry out regular clinical reviews to help ensure your treatment remains safe, appropriate and personalised.

Frequently Asked Questions

Can you lose weight on a low dose of GLP-1 medication?

Yes. Some people experience meaningful appetite reduction and weight loss on lower doses, particularly during the early stages of treatment. However, everyone's response is different, and some patients may require higher doses to achieve or maintain their goals.

Is GLP-1 microdosing officially recommended?

No. Microdosing is not currently an approved treatment strategy for licensed GLP-1 medications used for weight management. Any dose adjustments should be made by your prescribing clinician.

Can I stay on the same dose if it's working?

Possibly. If your clinician believes your current dose is providing good results and is well tolerated, they may recommend remaining on it for longer. This decision should always be based on your individual clinical circumstances.

Should I reduce my dose if I have side effects?

Don't reduce your medication without speaking to your healthcare provider. If you're experiencing side effects, contact your prescribing clinician—they can advise whether staying on your current dose for longer, adjusting your treatment plan, or exploring other options is appropriate.